From 2013 to 2023, there was a general decline in the market size value per capita for Hormones in Dosage Except Contraceptives and Antibiotics in Madagascar, as it decreased from $0.10 to $0.076. The largest year-on-year drop occurred from 2019 to 2020 with a relative stability following a slight recovery. Over the last two years up to 2023, the market contracted by about 12.6% cumulatively from $0.087 in 2021 to $0.076. The compound annual growth rate (CAGR) over the last five years was negative, indicating an average annual decrease in value.
Future trends to watch include the potential impact of economic improvements and healthcare reforms in Madagascar that could stabilize or reverse the current downward trend. External factors such as changes in global hormone pricing and domestic healthcare policies might also influence the market dynamics significantly.
